What are the recommended medications for a dry cough?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Medications for Dry Cough

First-Line Treatment

For dry cough, dextromethorphan at 60 mg is the recommended first-line treatment due to its superior safety profile and proven efficacy, while codeine should be avoided despite being commonly prescribed. 1, 2

Dextromethorphan Dosing

  • The optimal dose is 60 mg for maximum cough reflex suppression, not the standard over-the-counter doses of 15-30 mg which are subtherapeutic. 1, 2
  • Dextromethorphan is specifically recommended for chronic or acute bronchitis with substantial benefit (Grade A recommendation). 3, 1
  • It has a superior safety profile compared to opioid alternatives, with fewer adverse effects including less drowsiness, nausea, constipation, and no risk of physical dependence. 1, 2
  • Duration should be limited to short-term use, typically less than 7 days. 2

Alternative First-Line Options

Peripheral Cough Suppressants

  • Levodropropizine and moguisteine are recommended for short-term symptomatic relief in patients with chronic or acute bronchitis (Grade A recommendation). 3, 1
  • These peripheral agents work by anesthetizing stretch receptors in the respiratory passages rather than acting centrally. 4

Benzonatate

  • Benzonatate is FDA-approved for symptomatic relief of cough, acting peripherally by anesthetizing stretch receptors in the respiratory passages, lungs, and pleura. 4
  • It begins to act within 15-20 minutes with effects lasting 3-8 hours, and has no inhibitory effect on the respiratory center at recommended dosages. 4

Second-Line Treatment

Ipratropium Bromide

  • Ipratropium bromide is the only inhaled agent recommended for cough suppression with substantial benefit (Grade A recommendation). 3, 1
  • It should be tried before central antitussives in postinfectious cough. 1, 2
  • This is particularly useful for URI-related cough where central suppressants have limited efficacy. 3, 1

First-Generation Antihistamines

  • Promethazine or other first-generation sedating antihistamines can be added specifically for nocturnal cough due to their sedative properties. 2
  • These are particularly suitable when cough interferes with sleep, though caution is warranted in elderly patients due to increased fall risk. 5

Non-Pharmacologic Options

  • Simple home remedies like honey and lemon may be as effective as pharmacological treatments for benign viral cough and should be tried first. 1, 2
  • Menthol inhalation provides acute but short-lived cough suppression and can be used as an adjunct. 2

What NOT to Use

Codeine and Other Opioids

  • Codeine is NOT recommended as first-line despite being commonly prescribed, as it has no greater efficacy than dextromethorphan but significantly worse adverse effects including drowsiness, nausea, constipation, and risk of physical dependence. 1, 2, 5
  • For chronic bronchitis, codeine may be considered only if dextromethorphan fails (Grade B recommendation), but this is a lower grade than dextromethorphan's Grade A. 3

Other Ineffective Agents

  • Albuterol is not recommended for cough not due to asthma (Grade D recommendation). 3, 1
  • Over-the-counter combination cold medications (except older antihistamine-decongestant combinations) lack evidence of efficacy and are not recommended. 3, 5
  • Central cough suppressants have limited efficacy for URI-related cough and are not recommended for this indication (Grade D recommendation). 3, 1

Common Pitfalls to Avoid

  • Using subtherapeutic doses of dextromethorphan (15-30 mg instead of 60 mg) is the most common error. 1, 2
  • Prescribing codeine-based antitussives despite lack of efficacy advantage and increased side effects. 1, 5
  • Using central cough suppressants for URI-related cough where they have limited efficacy. 3, 1
  • Applying cough suppressants to productive cough where secretion clearance is beneficial—antitussives should be avoided in these cases. 2

References

Guideline

Cough Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cough Management with Dextromethorphan and Promethazine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cough Management in Elderly Alzheimer's Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.